[Retracted] Sagunja-Tang Improves Lipid Related Disease in a Postmenopausal Rat Model and HepG2 Cells

Figure 3

Cytotoxicity of MβCD and SGJT in HepG2 cells. HepG2 cells were treated with several concentrations of SGJT (250–1,000 μg/mL) for 8 h in 0.2% BSA-DMEM, and the cell viability was determined using WST assay (a). HepG2 cells were treated with 20 mg/mL MβCD and 30 μM simvastatin or several concentrations of SGJT (250–1,000 μg/mL) with 20 mg/mL MβCD for 8 h in 0.2% BSA-DMEM, and the cell viability was determined using WST assay (b). The data were mean ± SD from three samples for each group. Values not sharing a common alphabet as superscripts are significantly different from each other at the level of (ANOVA followed by Duncan’s test). Similar results were obtained in three separate experiments.

(a)

(b)